The Precision Peptide Company Inc. PNGAF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.25M | 568.00K | 305.10K | 685.00K | 1.32M |
| Total Receivables | 68.20K | 60.30K | 51.80K | 50.70K | 112.40K |
| Inventory | 259.00K | 35.90K | 45.60K | 49.90K | 69.40K |
| Prepaid Expenses | 621.90K | 433.40K | 77.20K | 164.00K | 45.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.20M | 1.10M | 479.70K | 949.80K | 1.54M |
|
|
|||||
| Total Current Assets | 2.20M | 1.10M | 479.70K | 949.80K | 1.54M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | 623.70K |
| Goodwill | -- | -- | -- | -- | 623.70K |
| Total Other Intangibles | -- | -- | -- | -- | 1.01M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.20M | 1.10M | 479.70K | 949.80K | 3.17M |
|
|
|||||
| Total Accounts Payable | 283.40K | 297.40K | 253.00K | 248.00K | 161.50K |
| Total Accrued Expenses | 20.80K | 28.40K | 28.50K | 38.30K | 55.50K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 304.20K | 325.80K | 281.50K | 286.30K | 217.00K |
|
|
|||||
| Total Current Liabilities | 304.20K | 325.80K | 281.50K | 286.30K | 217.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 304.20K | 325.80K | 281.50K | 286.30K | 217.00K |
|
|
|||||
| Common Stock & APIC | 8.83M | 7.06M | 6.13M | 5.92M | 3.83M |
| Retained Earnings | -8.67M | -7.66M | -7.31M | -6.08M | -3.70M |
| Treasury Stock & Other | 1.74M | 1.37M | 1.38M | 823.30K | 2.82M |
| Total Common Equity | 1.90M | 771.90K | 198.20K | 663.40K | 2.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.90M | 771.90K | 198.20K | 663.40K | 2.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.90M | 771.90K | 198.20K | 663.40K | 2.96M |
|
|
|||||